Benign neoplasm of other and ill-defined parts of digestive system

Description

pancreatic neuroendocrine tumor: Pancreatic endocrine tumor, also known as pancreatic neuroendocrine tumor (PNET), describes a group of endocrine tumors originating in the pancreas that are usually indolent and benign, but may have the potential to be malignant. They can be functional, exhibiting a hormonal hypersecretion syndrome, but can be non-functional presenting with non-specific symptoms and include insulinoma, glucagonoma, VIPoma, somatostatinoma (SSoma), PPoma and Zollinger-Ellison syndrome (ZES, or gastrinoma) and other ectopic hormone producing tumors (such as GRFoma) (see these terms).

Data source
FinnGen phenocode CD2_BENIGN_OTHERDIGESTIVE
Hospital Discharge registry ICD-10: D13
Cause of Death registry ICD-10: D13
Include CD2_BENIGN_OESOPHAGUS, CD2_BENIGN_STOMACH, CD2_BENIGN_SMALL_INTESTINE, CD2_BENIGN_LIVE_BILE, CD2_BENIGN_PANCREAS, CD2_BENIGN_ENDOCRINE_PANCREAS, CD2_BENIGN_DIGESTIVE_NOS
Level in the ICD-hierarchy 2
First defined in version DF2
Ontology
DOID 1799
GWAS catalog 1000045

Key figures

Sex All Female Male
Number of individuals 1397 893 504
Unadjusted prevalence (%) 1.05 1.19 0.88
Mean age at first event (years) 60.67 59.37 62.97
Median number of events / individual 1 1 1

Clinical metrics

Sex All Female Male
Recurrence within 6 months (%) 20.26 19.71 21.23
Case fatality at 5-years (%) 7.16 5.38 10.32

Associations